Author: Smead Capital Management

CNBC: Bill Smead on Health Care Stocks

Health care stocks are hated, but we’re buying them: Smead CEO By Tom DiChristopher Stocks Mentioned: MRK, PFE, AMGN For more information go to www.cnbc.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice.

⟶ Keep Reading

Bloomberg: Cole Smead discusses US Stocks and Stability

U.S. Stock Turnaround: Is Stability Here to Stay? By Angie Lau For more information go to www.bloomberg.com. Stocks Mentioned: BAC, C, JPM The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is

⟶ Keep Reading

Political Punching Bags

The United States has one of the most successful biotech/pharmaceutical industries and arguably the premier banking institutions in the world. During the current presidential race, populist politicians on both sides of the aisle have gained a great deal of popularity by turning these two industries into political punching bags.

⟶ Keep Reading

CNBC Squawk Box Europe: Cole Smead on US banks

Should you invest in US banks? Hosted by Geoff Cutmore and Karen Tso For more information go to www.cnbc.com. Stocks mentioned: BAC, C, JPM The information contained in this tv appearance represents SCM’s opinions, and should not be construed as personalized or individualized investment advice.

⟶ Keep Reading

Berkshire Hathaway Annual Letter: Cheap and Wonderful

At Smead Capital Management, we have great respect for the most successful long-duration investors. Warren Buffett is among those investors. He gives the public access to his thinking in his annual Berkshire Hathaway shareholder letter. In his recent 2015 letter, he reminded readers of a few of the things that should matter most to investors. We at Smead Capital Management like to buy wonderful companies at cheap prices. Buffet’s letter dwells on the need for businesses to be cheap in a wise way. He also reviews what makes a company “wonderful.”

⟶ Keep Reading

Modern Investor: Bill Smead on ‘The Big Long’

A-rated Smead: six reasons the US economy is the new ‘big long’ Modern Investor by Chris Sloley For more information go to www.moderninvestor.com. Stocks mentioned: JPM, WFC The information contained in this tv appearance represents SCM’s opinions, and should not be construed as personalized or

⟶ Keep Reading

CNBC: Bill Smead on Central Bank Policy

Central bank medicine becoming ‘poison’: Expert By Jacob Pramuk For more information go to www.cnbc.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. The securities

⟶ Keep Reading

CNBC Market Alert: Bill Smead on ‘Buying Action’

Don’t buy talk, buy action: Smead Hosted by Sara Eisen, Carl Quintanilla and Simon Hobbs For more information go to www.cnbc.com. The information contained in this tv appearance represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is

⟶ Keep Reading

The Big Long

I recently saw the movie, The Big Short. While the movie entertained as much as the book, the movie’s release coupled with the rough start to the year probably left a lot of investors feeling anxious. As long-duration common stock owners, we at Smead Capital Management believe a review of the circumstances preceding the financial meltdown of 2007-2009 and a comparison to where we are now in the U.S. economy would be helpful. Since residential real estate was the centerpiece of the movie, and traditionally is a centerpiece of our economy, we will dub our current view as “The Big Long.”

⟶ Keep Reading
Scroll to Top